Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Aug 19 · below the Ichimoku cloud · RSI 31 · MACD below its signal
None of the 29 investors followed here reported a position in AMIX in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a AMIX trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -27.6 | 10.3 | -11.2 | -12.8 | 17.6 | -25.8 | -44.8 | 40.4 | -20.7 | -21.4 | −73.9% | ||
| 2025 | -22.6 | -5.5 | -36.4 | 33.7 | -30.6 | -3.4 | -8.3 | -22.2 | -3.6 | -4.6 | 3.9 | -48.6 | −85.4% |
| 2024 | -22.9 | -24.5 | 7.0 | -29.4 | -57.9 | 9.4 | -36.2 | -10.6 | 19.4 | -65.6 | -23.6 | −96.4% |
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Klemp Walter V.Director | Stock Award(Grant) at price 0.00 per share. | 13K | — |
| Sep 2, 2026 | Hauser BradleyChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 27K | — |
| Sep 2, 2026 | Smith Trent NChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 15K | — |
| Sep 2, 2026 | Bisson LoriDirector | Stock Award(Grant) at price 0.00 per share. | 13K | — |
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.